MGMatthew R. Golden

Matthew R. Golden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew R. Golden has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decreases in Reported Sexually Transmitted Infections During the Time of COVID-19 in King County, WA: Decreased Transmission or Screening?

    by Anna Berzkalns, Christina S. Thibault, Lindley A. Barbee, Matthew R. Golden, Christine Khosropour, Roxanne P. Kerani

    Background: In response to the COVID-19 pandemic, Washington State's Stay Home, Stay Healthy (SHSH) order was implemented on March 24, 2020. We hypothesized that pandemic mitigation measures might reduce sexually transmitted infection (STI) screening and/or transmission. Methods: We used King County, WA STI surveillance and sexual health clinic (SHC) data from January 1, 2019, to July 31, 2020. We calculated mean weekly case counts for gonorrhea, primary and secondary (P&S) syphilis, male urethral gonorrhea, and early latent (EL) syphilis for 3 periods in 2020: pre-SHSH (January 1–March 23), SHSH (March 24–June 5), and reopening (June 6–July 31). Primary and secondary syphilis and male urethral gonorrhea were used as proxies for sexual behavior, and EL syphilis was used as a proxy for STI screening. We compared SHC visits (2019 vs. 2020) and SHC gonorrhea treatment practices (across 2020 periods). Results: Compared with January to July 2019, from January to July 2020, reported cases of gonorrhea, male urethral gonorrhea, P&S syphilis, and EL syphilis decreased by 9%, 5%, 16%, and 22%, respectively. Mean weekly case counts of gonorrhea, male urethral gonorrhea, and EL syphilis decreased pre-SHSH to SHSH, but all returned to pre-SHSH levels during reopening. Sexual health clinic visits during SHSH were 55% lower in 2020 than in 2019. In the SHC during SHSH, ceftriaxone treatment of gonorrhea decreased, whereas cefixime/cefpodoxime treatment and gonorrhea treatment with no testing increased. Conclusions: Decreases in reported STIs concurrent with COVID-19 SHSH may reflect a true decline in STI transmission. However, the larger decreases in asymptomatic infections indicate that much of the observed decrease was likely due to decreased screening.


  • Evaluation of an Automated Express Care Triage Model to Identify Clinically Relevant Cases in a Sexually Transmitted Disease Clinic

    by Laura C. Chambers, Lisa E. Manhart, David A. Katz, Matthew R. Golden, Lindley A. Barbee, Julia C. Dombrowski

    Many sexually transmitted disease (STD) clinics offer testing-only “express” visits. We evaluated the express care triage algorithm that is based on a computer-assisted self-interview (CASI) used in the Public Health—Seattle and King County STD Clinic. During the analysis period, patients received a clinician evaluation irrespective of triage status. In this cross-sectional study, we compared the algorithm triage status to a disease-focused outcome determined by medical record review. We defined a patient as “needing a standard visit” if they reported key symptoms, received empiric treatment, or were diagnosed with an infection or syndrome at the same visit. We estimated the sensitivity of the algorithm for identifying patients who needed a standard visit and identified the characteristics of patients who could have received express care but were excluded from it by the algorithm. Between October 2010 and June 2015, patients completed a CASI at 32,113 visits; 23% were triaged by the algorithm to express care. The triage status was appropriate for 21,337 (87%) men and 6259 (82%) women. The algorithm had 95% and 98% sensitivity for identifying men and women, respectively, needing standard visits. The most common reason for mistriage to express care was patient report of symptoms to clinicians that they did not disclose to the CASI. Of women who could have received express care, only 33% were triaged to it by the algorithm; the remainder was triaged to standard visits, primarily for health service indications. The CASI-based algorithm accurately identified patients who were eligible for express care based on a disease-focused outcome.


  • Chlamydia Screening Coverage Estimates Derived Using Healthcare Effectiveness Data and Information System Procedures and Indirect Estimation Vary Substantially

    by Jennifer M. Broad, Lisa E. Manhart, Roxanne P. Kerani, Delia Scholes, James P. Hughes, Matthew R. Golden

    Screening coverage is an important determinant of chlamydial control program success. The aim of this study was to compare chlamydial screening coverage estimates. We compared 9 estimates among women aged 15 to 25 years in Washington State, 2009. Four used Healthcare Effectiveness Data and Information System (HEDIS) procedures among Group Health enrollees. Separate HEDIS estimates assessed all enrollees and the subset of women who used services; for each group, separate estimates defined the sexually active population using HEDIS methods or National Survey of Family Growth (NSFG) data. Three indirect screening estimates used census and NSFG data to define the population's size and derived the number of tests performed by dividing the number of reported cases by test positivity defined using data from different laboratories, adjusted for repeat testing. A fourth indirect estimate was adjusted for reason for testing. A direct-indirect estimate combined data on the number of tests performed in reporting laboratories and an indirect estimate of tests performed elsewhere. Healthcare Effectiveness Data and Information System procedures and NSFG data yielded similar estimates of the percentage of women who were sexually active (60% vs. 61%). Screening coverage estimated by HEDIS was higher among Group Health users (43.6%) than among all enrollees (34.2%). Indirect screening coverage estimates varied from 46.4% to 68.7%. The direct-indirect estimate, which included a direct measure of the number of tests performed to identify 52% of reported cases, was 57.6%. Most sexually active women aged 15 to 25 years in Washington State were screened for chlamydia in 2009. Healthcare Effectiveness Data and Information System methods may underestimate screening coverage. Health departments can derive population-based coverage estimates using data from large laboratories.


  • Open Access

    Understanding Barriers to Routine HIV Screening: Knowledge, Attitudes, and Practices of Healthcare Providers in King County, Washington

    by Alexandra Shirreffs, David P. Lee, Jsani Henry, Matthew R. Golden, Joanne D. Stekler

    In 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV screening in healthcare settings for persons between 13 and 64 years old. In 2010, the Washington Administrative Code (WAC) was changed to align testing rules with these recommendations. We designed this survey to ascertain the current state of HIV testing and barriers to routine screening in King County, Washington. Between March 23 and April 16, 2010, a convenience sample of healthcare providers completed an online survey. Providers answered true-false and multiple choice questions about national recommendations and the WAC, policies in their primary clinical settings, and their personal HIV testing practices. Providers were asked to agree or disagree whether commonly reported barriers limited their implementation of routine HIV screening. Although 76% of the 221 respondents knew that the CDC recommended routine HIV screening for persons regardless of their risk, 99 (45%) providers reported that their primary clinical setting had a policy to target testing based on patient risk factors. Forty-four (20%) providers reported that their primary clinical setting had a policy of routine HIV screening, 54 (25%) reported no official policy, and 15 (7%) did not know whether a policy existed. Only 11 (5%) providers offer HIV testing to all patients at initial visits. When asked about barriers to routine screening, 57% of providers agreed that perception that their patient population is low risk limits the number of HIV tests they perform. Only 26 (13%) providers agreed that concern about reimbursement posed a barrier to testing. Most providers participating in this survey continue to target HIV testing, despite knowledge of national recommendations. Efforts are still needed to educate providers and policymakers, clarify the recent WAC revisions, and implement structural changes in order to increase HIV testing in Washington State.


  • Failure of Serosorting to Protect African American Men Who Have Sex With Men From HIV Infection

    by Matthew R. Golden, Julia C. Dombrowski, Roxanne P. Kerani, Joanne D. Stekler

    Background: Serosorting is the practice of choosing sex partners or selectively using condoms based on a sex partner's perceived HIV status. The extent to which serosorting protects African American (AA) and Hispanic men who have sex with men (MSM) is unknown. Methods: We analyzed data collected from MSM sexually transmitted diseases clinic patients in Seattle, WA, 2001–2010. Men were asked about the HIV status of their anal sex partners in the prior year and about their condom use with partners by partner HIV status. We defined serosorters as MSM who had unprotected anal intercourse (UAI) only with partners of the same HIV status, and compared the risk of testing HIV positive among serosorters and men who reported having UAI with partners of opposite or unknown HIV status (ie, nonconcordant UAI). We used generalized estimating equations to evaluate the association of serosorting with testing HIV positive. Results: A total of 6694 MSM without a prior HIV diagnosis were tested during 13,657 visits; 274 men tested HIV positive. Serosorting was associated with a lower risk of testing HIV positive than nonconcordant UAI among white MSM (2.1 vs. 4.5%, odds ratio [OR]: 0.45, 95% confidence interval [CI]: 0.34–0.61), but not AA MSM (6.8 vs. 6.0%, OR: 1.1, 95% CI: 0.57–2.2). Among Hispanics, the risk of testing HIV positive was lower among serosorters than men engaging in nonconcordant UAI, though this was not significant (4.1 vs. 6.0%, OR: 0.67, 95% CI: 0.36–1.2). Conclusions: In at least some AA MSM populations, serosorting does not seem to be protective against HIV infection.


  • Open Access

    Use of a home-use test to diagnose HIV infection in a sex partner: a case report

    by David A Katz, Matthew R Golden, Joanne D Stekler

    Home-use HIV tests have the potential to increase testing and may be used by sex partners to inform sexual decision-making. To our knowledge, this is the first report of an individual diagnosed with HIV using a home-use test with a sex partner.


  • Neisseria Gonorrhoeae Infections

    by Matthew R. Golden, H. Hunter Handsfield


  • An Evaluation of HIV Partner Counseling and Referral Services Using New Disposition Codes

    by Matthew R. Golden, Joanne Stekler, James B. Kent, James P. Hughes, Robert W. Wood

    Background: New Centers for Disease Control recommendations suggest that all persons with newly diagnosed HIV receive partner counseling and referral services (PCRS). Methods: We evaluated the King County, WA, PCRS program using a new set of disposition codes that disaggregate the components of PCRS (notification, testing, and test results), distinguish verified and unverified outcomes, and differentiate outcomes that occur before and after cases receive PCRS. Results: Between 2005 and 2007, 427 (65%) of 659 persons with newly diagnosed HIV received PCRS. The number of cases staff needed to interview to identify 1 new case of HIV varied from 12.2 to 47.4 depending on whether number needed to interview was defined to include both verified and unverified outcomes and whether it excluded partners diagnosed with HIV before cases’ receipt of PCRS. Age <25, testing HIV negative within the last year, receipt of PCRS within 58 days of HIV diagnoses, and participation in a program to link persons with HIV to medical care were significantly associated notifying more partners. Conclusions: PCRS evaluations may overestimate success because of limitations inherent in Centers for Disease Control PCRS disposition codes. Efforts to promote frequent HIV testing, assure timely provision of PCRS, and integrate PCRS with programs that link patients to care may improve PCRS outcomes.